Search
for
Sort by
Research 661–690 of 1000+
- <i>Polycystic Ovary Syndrome in Adolescence</i>
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Diet and hair loss: effects of nutrient deficiency and supplement use
- Characteristic features of Japanese women's hair with aging and with progressing hair loss
- Infertility in Polycystic Ovary Syndrome: Focus on Low-Dose Gonadotropin Treatment
- Management of Hair Loss
- Nutrition and hair
- Topical Delivery of Protein and Peptide Using Novel Cell Penetrating Peptide IMT-P8
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Topical liposome delivery of molecules to hair follicles in mice
- The diagnosis of polycystic ovary syndrome: the criteria are insufficiently robust for clinical research
- Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome
- Exploring the “Thyroid–Skin Connection”: Concepts, Questions, and Clinical Relevance
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Role of Zinc in Mucosal Health and Disease: A Review of Physiological, Biochemical, and Molecular Processes
- Putative role for insulin resistance in depression risk in polycystic ovary syndrome
- 5α-Reduced glucocorticoids: a story of natural selection
- The effect of menopause on the skin and other connective tissues
- Acquired scalp alopecia. Part I: A review
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- 3D printed microneedles: revamping transdermal drug delivery systems
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
- Inhibition of Rat 5<i>α</i>-Reductase Activity and Testosterone-Induced Sebum Synthesis in Hamster Sebocytes by an Extract of<i>Quercus acutissima</i>Cortex
- Prevalence of Polycystic Ovary Syndrome in Girls Aged 14–18 Years in Isfahan, Iran
- Vitamin D receptor polymorphisms and the polycystic ovary syndrome: A systematic review